<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type (species) <break/>or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">gene (Homo sapiens)</td><td align="left" valign="bottom">RXRA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NCBI Gene ID:6256; <break/>NM_002957</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">gene (H. sapiens)</td><td align="left" valign="bottom">PPARG</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NCBI Gene ID:5468; <break/>NM_138711</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">gene (H. sapiens)</td><td align="left" valign="bottom">PPARD</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NCBI Gene ID:5467; <break/>NM_006238</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">strain, strain background <break/>(Mus musculus)</td><td align="left" valign="bottom">Kdm6a<sup>F</sup></td><td align="left" valign="bottom">other</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Generated by Dr. Lukas Wartman <break/>(Washington University School of <break/>Medicine) with ES cells obtained <break/>from EUCOMM with the Kdm6a<sup>tm1a</sup> <break/><sup>(EUCOMM)Wtsi</sup> allele <break/>(manuscript in preparation)</td></tr><tr><td align="left" valign="bottom">strain, strain background <break/>(M. musculus)</td><td align="left" valign="bottom">Trp53Flox; B6.129P2- <break/>Trp53tm1brn/J</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">The Jackson <break/>Laboratory:008462; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:008462">IMSR_JAX:008462</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">genetic reagent</td><td align="left" valign="bottom">Ad5CMVCre-eGFP <break/>adenovirus</td><td align="left" valign="bottom">University of Iowa <break/>Viral Vector Core</td><td align="left" valign="bottom">VVC-U of Iowa:1174</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">cell line (M. musculus)</td><td align="left" valign="bottom">MCB6C</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Clonal organoid line generated <break/>from tumor bearing bladder of male <break/>C57BL/6 mouse treated with BBN</td></tr><tr><td align="left" valign="bottom">cell line (M. musculus)</td><td align="left" valign="bottom">DKO 431.A</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">clonal organoid line generated <break/>from the urothelium of a male <break/>Trp53<sup>Flox/Flox</sup>;Kdm6a<sup>Flox</sup> mouse</td></tr><tr><td align="left" valign="bottom">cell line (M. musculus)</td><td align="left" valign="bottom">WT</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Organoid lines generated from the <break/>urothelium of wild-type male mice <break/>resulting from cross between <break/>Trp53<sup>Flox/+</sup> and Kdm6a<sup>Flox/+</sup> mice</td></tr><tr><td align="left" valign="bottom">cell line (M. musculus)</td><td align="left" valign="bottom">"Trp53-/-; <break/>Kdm6a-"; DKO</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Organoid lines were generated <break/>from the urothelium of Trp53<sup>Flox/Flox</sup>; <break/>Kdm6a<sup>Flox</sup> male mice and then <break/>infected with Ad5CMVCre-eGFP <break/>adenovirus in vitro</td></tr><tr><td align="left" valign="bottom">cell line (M. musculus)</td><td align="left" valign="bottom">"Kdm6a-"; KKO</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Organoid lines were generated <break/>from the urothelium of Kdm6a<sup>Flox</sup> <break/>male mice and then infected with <break/>Ad5CMVCre-eGFP adenovirus in vitro</td></tr><tr><td align="left" valign="bottom">cell line (M. musculus)</td><td align="left" valign="bottom">"Trp53-/-"; PKO</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Organoid lines were generated <break/>from the urothelium of Trp53<sup>Flox/Flox</sup> <break/>male mice and then infected with <break/>Ad5CMVCre-eGFP adenovirus in vitro</td></tr><tr><td align="left" valign="bottom">cell line (M. musculus)</td><td align="left" valign="bottom">DKO 431.A.EV</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">DKO 431.A organoid line infected <break/>with retrovirus carrying <break/>pBABE puro empty vector</td></tr><tr><td align="left" valign="bottom">cell line (M. musculus)</td><td align="left" valign="bottom">DKO 431. <break/>A.RXRAwt</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">DKO 431.A organoid line infected <break/>with retrovirus <break/>carrying pBABE puro RXRA</td></tr><tr><td align="left" valign="bottom">cell line (M. musculus)</td><td align="left" valign="bottom">DKO 431.A.RXRAS427F</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">DKO 431.A organoid line infected <break/>with retrovirus carrying <break/>pBABE puro RXRA S427F</td></tr><tr><td align="left" valign="bottom">cell line (H. sapiens)</td><td align="left" valign="bottom">JMSU-1</td><td align="left" valign="bottom">other</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_2081">CVCL_2081</ext-link></td><td align="left" valign="bottom">obtained from Dr. David <break/>Solit (MSKCC)</td></tr><tr><td align="left" valign="bottom">cell line (H. sapiens)</td><td align="left" valign="bottom">575A</td><td align="left" valign="bottom">other</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_7941">CVCL_7941</ext-link></td><td align="left" valign="bottom">obtained from Dr. David <break/>Solit (MSKCC)</td></tr><tr><td align="left" valign="bottom">cell line (H. sapiens)</td><td align="left" valign="bottom">UM-UC-3</td><td align="left" valign="bottom">other</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_1783">CVCL_1783</ext-link></td><td align="left" valign="bottom">obtained from Dr. David <break/>Solit (MSKCC)</td></tr><tr><td align="left" valign="bottom">cell line (H. sapiens)</td><td align="left" valign="bottom">Lenti-X 293T</td><td align="left" valign="bottom">Clontech</td><td align="left" valign="bottom">Clontech:632180</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">cell line (H. sapiens)</td><td align="left" valign="bottom">JMSU-1 RXRA WT</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">JMSU-1 cell line infected with <break/>retrovirus carrying <break/>pBABE puro RXRA</td></tr><tr><td align="left" valign="bottom">cell line (H. sapiens)</td><td align="left" valign="bottom">JMSU-1 RXRA S427F</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">JMSU-1 cell line infected <break/>with retrovirus carrying <break/>pBABE puro RXRA S427F</td></tr><tr><td align="left" valign="bottom">cell line (H. sapiens)</td><td align="left" valign="bottom">JMSU-1 RXRA S427Y</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">JMSU-1 cell line infected with <break/>retrovirus carrying <break/>pBABE puro RXRA S427Y</td></tr><tr><td align="left" valign="bottom">cell line (H. sapiens)</td><td align="left" valign="bottom">575A RXRA WT</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">575A cell line infected with <break/>retrovirus carrying <break/>pBABE puro RXRA</td></tr><tr><td align="left" valign="bottom">cell line (H. sapiens)</td><td align="left" valign="bottom">575A RXRA S427F</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">575A cell line infected with <break/>retrovirus carrying <break/>pBABE puro RXRA S427F</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">anti-PPARG (81B8) <break/>(rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cell Signaling <break/>Technology:2443; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_823598">AB_823598</ext-link></td><td align="left" valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">anti-PPARD <break/>(rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Abcam:ab178866</td><td align="left" valign="bottom">(1:5000)</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">anti-RXRA (D6H10) <break/>(rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cell Signaling <break/>Technology:3085</td><td align="left" valign="bottom">(1:1200)</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">anti-beta-Actin <break/>(mouse monoclonal)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Sigma-Aldrich:A5441; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_476744">AB_476744</ext-link></td><td align="left" valign="bottom">(1:50000)</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">anti-GAPDH (D16H11) <break/>(rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cell Signaling <break/>Technology:5174; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10622025">AB_10622025</ext-link></td><td align="left" valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">anti-rabbit IgG, <break/>HRP (goat)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cell Signaling <break/>Technology:7074; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2099233">AB_2099233</ext-link></td><td align="left" valign="bottom">(1:7500)</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">anti-mouse IgG, <break/>HRP (horse)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cell Signaling <break/>Technology:7076; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_330924">AB_330924</ext-link></td><td align="left" valign="bottom">(1:7500)</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">anti-RXRA (K8508) <break/>(mouse monoclonal)</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="left" valign="bottom">R&amp;D Systems: <break/>PP-K8508-00; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2182738">AB_2182738</ext-link></td><td align="left" valign="bottom">(5 &#181;g)</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">anti-H3K27Ac <break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Abcam:ab4729; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2118291">AB_2118291</ext-link></td><td align="left" valign="bottom">(0.4 &#181;g)</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">PPRE X3-TK-luc; <break/>DR1 reporter <break/>(plasmid)</td><td align="left" valign="bottom">Addgene; PMID 9539737</td><td align="left" valign="bottom">Addgene:1015</td><td align="left" valign="bottom">plasmid was deposited <break/>by Bruce Spiegelman</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pGL3-RARE-luciferase; <break/>DR5 reporter (plasmid)</td><td align="left" valign="bottom">Addgene; PMID 16818722</td><td align="left" valign="bottom">Addgene:13458</td><td align="left" valign="bottom">plasmid was deposited <break/>by T. Michael Underhill</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pRL-SV40 (plasmid)</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Promega:E2231</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pCL-ampho (plasmid)</td><td align="left" valign="bottom">other</td><td align="left" valign="bottom"/><td align="left" valign="bottom">obtained from <break/>Dr. Charles Sawyers (MSKCC)</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">VSVG (plasmid)</td><td align="left" valign="bottom">other</td><td align="left" valign="bottom"/><td align="left" valign="bottom">obtained from <break/>Dr. Charles Sawyers (MSKCC)</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pCMV6-XL4 RARA <break/>(plasmid)</td><td align="left" valign="bottom">OriGene</td><td align="left" valign="bottom">OriGene:SC119566</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pCMV6-XL4 PPARG <break/>(plasmid)</td><td align="left" valign="bottom">OriGene</td><td align="left" valign="bottom">OriGene:SC108192</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pCMV6-XL4 PPARG <break/>Q286P (plasmid)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Q286 was mutated via site-directed <break/>mutagenesis of pCMV6-XL4 PPARG</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pCMV6-XL4 PPARG <break/>E471A (plasmid)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">E471 was mutated via site-directed <break/>mutagenesis of pCMV6-XL4 PPARG</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pCMV6-XL4 PPARG <break/>Y477S (plasmid)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Y477 was mutated via site-directed <break/>mutagenesis of pCMV6-XL4 PPARG</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pCMV6-XL4 PPARG <break/>Y477X (plasmid)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Y477 was deleted via site-directed <break/>mutagenesis of pCMV6-XL4 PPARG</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pCMV6-XL4 empty <break/>vector (plasmid)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">generated by digesting pCMV6-XL4 <break/>PPARG with NotI to remove PPARG <break/>and by ligating the plasmid ends <break/>with T4 DNA ligase</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pBABE puro <break/>RXRA (plasmid)</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">Addgene:11441</td><td align="left" valign="bottom">deposited by Ronald Kahn</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pBABE puro RXRA <break/>S427F (plasmid)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">S427 was mutated via site-directed <break/>mutagenesis of pBABE puro empty vector</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pBABE puro RXRA <break/>S427Y (plasmid)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">S427 was mutated via site-directed <break/>mutagenesis of pBABE puro empty vector</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pBABE puro RXRA <break/>E453A (plasmid)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">E453 was mutated via site-directed <break/>mutagenesis of pBABE puro empty vector</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pBABE puro RXRA <break/>S427F/E453A (plasmid)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">E453 was mutated via site-directed <break/>mutagenesis of pBABE puro RXRA S427F</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pBABE puro empty <break/>vector (plasmid)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">generated by digesting pBABE <break/>puro RXRA with EcoRI to remove <break/>RXRA and by ligating the plasmid <break/>ends with T4 DNA ligase</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pCMV6-XL4 PPARD <break/>(plasmid)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Human PPARD was cloned <break/>from JMSU-1 epithelial bladder <break/>cancer cells and inserted <break/>into the pCMV6-XL4</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pCMV6-XL4 PPARD <break/>Y441S (plasmid)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Y441 was mutated via site-directed <break/>mutagenesis of pCMV6-XL4 PPARD</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pCMV6-XL4 PPARD <break/>Y441X (plasmid)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Y441 was deleted via site-directed <break/>mutagenesis of pCMV6-XL4 PPARD</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">ON-TARGETplus <break/>Non-targeting <break/>Pool (siRNA)</td><td align="left" valign="bottom">Dharmacon</td><td align="left" valign="bottom">Dharmacon: <break/>D-001810-10-20</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">ON-TARGETplus Human <break/>PPARG siRNA</td><td align="left" valign="bottom">Dharmacon</td><td align="left" valign="bottom">Dharmacon: <break/>L-003436-00-0005</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">ON-TARGETplus Human <break/>PPARD siRNA</td><td align="left" valign="bottom">Dharmacon</td><td align="left" valign="bottom">Dharmacon: <break/>L-003435-00-0005</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">commercial assay or kit</td><td align="left" valign="bottom">Dual-Glo Luciferase <break/>Assay System</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Promega:E2940</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">commercial assay or kit</td><td align="left" valign="bottom">CellTiter-Glo</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Promega:G7571</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">commercial assay or kit</td><td align="left" valign="bottom">Ovation Ultraflow <break/>System V2</td><td align="left" valign="bottom">NuGen</td><td align="left" valign="bottom">NuGen:0344-32</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">Pioglitazone</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Sigma-Aldrich:E6910</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">GW 0742</td><td align="left" valign="bottom">Tocris</td><td align="left" valign="bottom">Tocris:2229</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">SR 11237</td><td align="left" valign="bottom">Tocris</td><td align="left" valign="bottom">Tocris:3411</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">all-trans-Retinoic <break/>Acid (ATRA)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Sigma-Aldrich:R2625</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">GSK 0660</td><td align="left" valign="bottom">Tocris</td><td align="left" valign="bottom">Tocris:3433</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">ST247</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Sigma-Aldrich:SML0424</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">T0070907</td><td align="left" valign="bottom">Cayman Chemical</td><td align="left" valign="bottom">Cayman Chemical:10026</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">software, algorithm</td><td align="left" valign="bottom">GROMACS 5.1.3</td><td align="left" valign="bottom">DOI: 10.1016/j.softx. <break/>2015.06.001</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014565">SCR_014565</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">software, algorithm</td><td align="left" valign="bottom">MSMBuilder 2.8</td><td align="left" valign="bottom">PMID: 22125474</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">software, algorithm</td><td align="left" valign="bottom">Chimera</td><td align="left" valign="bottom">PMID: 15264254; <break/><ext-link ext-link-type="uri" xlink:href="http://www.rbvi.ucsf.edu/chimera">http://www.rbvi.ucsf.edu/chimera</ext-link></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_004097">SCR_004097</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">mKDM6A Forward <break/>(primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' CGAGAAAGGAAATGTG <break/>AGAGCAAGG 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">mKDM6A Reverse 4 <break/>(primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' CTGGCAGGATATGATA <break/>GCAATGTG 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">oIMR8543 (primer)</td><td align="left" valign="bottom">The Jackson Laboratory; <break/><ext-link ext-link-type="uri" xlink:href="https://www2.jax.org/protocolsdb/f?p=116:2:0::NO:2:P2_MASTER_PROTOCOL_ID,P2_JRS_CODE:3226,008462">https://www2.jax.org/protocolsdb/f?p=116:2:0::NO:2:P2_MASTER_PROTOCOL_ID,P2_JRS_CODE:3226,008462</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' GGTTAAACCCAGCT <break/>TGACCA 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">oIMR8544 (primer)</td><td align="left" valign="bottom">The Jackson Laboratory; <break/><ext-link ext-link-type="uri" xlink:href="https://www2.jax.org/protocolsdb/f?p=116:2:0::NO:2:P2_MASTER_PROTOCOL_ID,P2_JRS_CODE:3226,008462">https://www2.jax.org/protocolsdb/f?p=116:2:0::NO:2:P2_MASTER_PROTOCOL_ID,P2_JRS_CODE:3226,008462</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' GGAGGCAGAGACA <break/>GTTGGAG 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">PPARD.qPCR.Fwd.1 <break/>(primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' ATGCACCAACGA <break/>GGCTGATG 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">PPARD.qPCR.Rev.1 <break/>(primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="middle">5' CTGCTCCATGGCT <break/>GATCTCC 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">PPARG fwd1 (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' ATGCCTTGCAGT <break/>GGGGATGTC 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">PPARG rev1 (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' GAGGTCAGCGGA <break/>CTCTGGATTC 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">hPLIN2 fwd1 (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' AGTGCTCTGCCC <break/>ATCATCCAG 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">hPLIN2 rev1 (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' TCACAGCGCCTT <break/>TGGCAT TG 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">FABP4 fwd1 (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' ACTGCAGCTTCCT <break/>TCTCACCTTG 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">FABP4 rev1 (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' TGCCAGCCACTT <break/>TCCTGGTG 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">mPlin2 Fwd1 (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' GTGCCCTGCCC <break/>ATCATCC 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">mPlin2 Rev1 (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' TTACGGCACCTCT <break/>GGCACTG 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">mFabp4 Fwd1 (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' TGCAGCCTTTCTCA <break/>CCTGGAAG 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">mFabp4 Rev1 (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="middle">5' GCCTGCCACTTTCC <break/>TTGTGG 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">RXRA fwd1 (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' ACAAGACGGAGC <break/>TGGGCTG 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">RXRA rev2 (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="middle">5' GGCTGCTCTGGGT <break/>ACTTGTGC 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">RXRA E453A SDM For <break/>(primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' acaccttccttatggccat <break/>gctggaggcgccg 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">RXRA E453A SDM Rev <break/>(primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' cggcgcctccagcatggcc <break/>ataaggaaggtgt 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="middle">RXRa S427F-F (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' CCG GCT CTG CGC TTT <break/>ATC GGG CTC AAA T 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">RXRa S427F-R (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="middle">5' CAT TTG AGC CCG ATA <break/>AAG CGC AGA GCC G 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">RXRa S427Y-F (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' CCG GCT CTG CGC TAT <break/>ATC GGG CTC AAA T 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">RXRa S427Y-R (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' CAT TTG AGC CCG ATA <break/>TAG CGC AGA GCC G 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">F hPPARGQ286P (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' ccacggagcgaaacgg <break/>gcagccctgaaag 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">R hPPARGQ286P (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' ctttcagggctgcccgttt <break/>cgctccgtgg 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">F hPPARGE471A (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' agtccttgtagatcgcctg <break/>caggagcggg 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">R hPPARGE471A (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' cccgctcctgcaggcgat <break/>ctacaaggact 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">PPARG Y477S For SDM <break/>(primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' GAGATCTACAAGGACTTGAG <break/>CTAGCAGAGAGTCCTGAGC 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">PPARG Y477S Rev SDM <break/>(primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' GCTCAGGACTCTCTGCTAGCT <break/>CAAGTCCTTGTAGATCTC 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">PPARG Y477X For SDM <break/>(primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' GATCTACAAGGACTTGTAG <break/>TAGCAGAGAGTCCTGA 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">PPARG Y477X Rev SDM <break/>(primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' TCAGGACTCTCTGCTACTAC <break/>AAGTCCTTGTAGATC 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">PPARD Y441S For (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' AGATCTACAAGGACATGAG <break/>CTAACGGCGGCACCCAG 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">PPARD Y441S Rev (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' CTGGGTGCCGCCGTTA <break/>GCTCATGTCCTTGTAGATCT 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">PPARD Y441X For (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' GATCTACAAGGACATGTGA <break/>TAACGGCGGCACCCAGG 3'</td></tr><tr><td align="left" valign="middle">sequence-based reagent</td><td align="left" valign="bottom">PPARD Y441X Rev (primer)</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5' CCTGGGTGCCGCCGTTATC <break/>ACATGTCCTTGTAGATC 3'</td></tr></tbody></table></table-wrap>